SFS
JSPR icon

Sowell Financial Services’s Jasper Therapeutics JSPR Stock Holding History

Sowell Financial Services’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,400
Closed -$24.8K – 1148
2025
Q3 		$24.8K Sell
10,400
-6,903
-40% -$20.9K ﹤0.01% 1062
2025
Q2 		$96K Sell
17,303
-3,522
-17% -$17.3K ﹤0.01% 1011
2025
Q1 		$89.5K Sell
20,825
-7,218
-26% -$48K ﹤0.01% 978
2024
Q4 		$600K Buy
+28,043
New +$584K 0.03% 393

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Sowell Financial Services's JSPR Position: Q4 2025 in Review

Sowell Financial Services sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 10,400 shares — an estimated $24.8K sold.

Sowell Financial Services first reported a position in JSPR in Q4 2024 and held it in 4 quarters. The position peaked at $600K in Q4 2024. 55 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Sowell Financial Services reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Sowell Financial Services sold 10,400 Jasper Therapeutics shares in Q4 2025, an estimated $24.8K.
  • Sowell Financial Services first reported a position in Jasper Therapeutics in Q4 2024 and held it in 4 quarters.
  • Sowell Financial Services's Jasper Therapeutics position peaked at $600K in Q4 2024.
  • 55 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Sowell Financial Services's 13F filing for Q4 2025, filed 21 Jan 2026.